Spots Global Cancer Trial Database for Clinical Study of Epoetin Beta to Chemotherapy-Induced Anemia (CIA) Patients
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Clinical Study of Epoetin Beta to Chemotherapy-Induced Anemia (CIA) Patients
Official Title: A Phase Ⅲ Randomized Double-Blind Placebo-Controlled Study of Epoetin Beta for the Treatment of Chemotherapy-Induced Anemia (CIA) in Cancer Patients
Study ID: NCT00628043
Conditions
Study Description
Brief Summary: This is a study to investigate the clinical efficacy and safety of epoetin beta 36,000 IU compared with placebo when administrated subcutaneously (s.c.) once-weekly for 12 weeks to anemic patients with lung cancer or gynecologic cancer undergoing chemotherapy.
Detailed Description:
Eligibility
Minimum Age: 20 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Chubu Region, Chubu, , Japan
Chugoku/Shikoku Region, Chugoku/Shikoku, , Japan
Hokkaido/Tohoku Region, Hokkaido/Tohoku, , Japan
Kanto/Koshinetsu Region, Kanto/Koshinetsu, , Japan
Kinki/Hokuriku Region, Kinki/Hokuriku, , Japan
Kyushu Region, Kyushu, , Japan
Contact Details
Name: Yoshito Suzuki
Affiliation: Chugai Pharmaceutical
Role: STUDY_CHAIR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
